Risks of Death and Severe Disease in Patients With Middle East Respiratory Syndrome Coronavirus, 2012-2015.

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen, first recognized in 2012, with a high case fatality risk, no vaccine, and no treatment beyond supportive care. We estimated the relative risks of death and severe disease among MERS-CoV patients in the Middle East betwe...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Epidemiology Vol. 184; no. 6; pp. 460 - 465
Autores principales: Rivers, Caitlin M., Majumder, Maimuna S., Lofgren, Eric T.
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA 9/15/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=118129650&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 118129650
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00029262
        1X1
      jtl: American Journal of Epidemiology
      issn: 00029262
      maglogo: N
    pubinfo:
      dt: 9/15/2016
      vid: 184
      iid: 6
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        118129650
        118129650
        118129650
        10.1093/aje/kww013
        118129650
      ppf: 460
      ppct: 5
      formats:
      tig:
        atl: Risks of Death and Severe Disease in Patients With Middle East Respiratory Syndrome Coronavirus, 2012-2015.
      aug:
        au:
          Rivers, Caitlin M.
          Majumder, Maimuna S.
          Lofgren, Eric T.
        affil: Network Dynamics and Simulation Science Laboratory, Biocomplexity Institute of Virginia Tech, Virginia Polytechnic Institute and State University, Blacksburg, Virginia
      sug:
        subj:
          Middle East Respiratory Syndrome Coronavirus
          Mortality Risk Factors
          Epidemiology
          Coronavirus Infections Risk Factors
          Human
          Male
          Female
          Regression
          Poisson Distribution
          Age Factors
          Comorbidity
          Algorithms
          Social Determinants of Health
          Health Status Disparities
          Severity of Illness
          Descriptive Statistics
          Confidence Intervals
          Data Analysis Software
          P-Value
          Record Review
          Adult
          Middle Age
          Aged
          Age of Onset
          Funding Source
          Coronavirus Infections Prognosis
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen, first recognized in 2012, with a high case fatality risk, no vaccine, and no treatment beyond supportive care. We estimated the relative risks of death and severe disease among MERS-CoV patients in the Middle East between 2012 and 2015 for several risk factors, using Poisson regression with robust variance and a bootstrap-based expectation maximization algorithm to handle extensive missing data. Increased age and underlying comorbidity were risk factors for both death and severe disease, while cases arising in Saudi Arabia were more likely to be severe. Cases occurring later in the emergence of MERS-CoV and among health-care workers were less serious. This study represents an attempt to estimate risk factors for an emerging infectious disease using open data and to address some of the uncertainty surrounding MERS-CoV epidemiology.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N